The goal of treatment in obesity or overweight is weight management. Along with diet, exercise, and modification of activity and eating behavior, in many cases, drugs such as Reesize may be chosen by your doctor to be an important component of weight management strategies. Thus Reesize is the adjunctive treatment of choice in obesity management.
The People Who may Expect Best Response from Reesize
Those who have BMI hovering around 29 or those who have illnesses, with overweight or obesity as a component, with BMI around 25 would benefit from Reesize, specially when diet and exercise alone fail to reduce weight. If you have BMI around 25 and also have other complicating illnesses, such as, high blood pressure, diabetes, and elevated blood cholesterol or triglycerides. These are known risk factors for atherosclerosis or other cardiovascular disease. Reesize promotes weight loss by preventing the digestion and absorption of dietary fat.
It works by inhibiting the gastric and pancreatic enzyme known as lipase, which breaks down triglycerides in the intestine. Since the absorbable fatty acids are derived from triglycerides, there is drastic reduction of fat absorption from diet. This reduces rate of weight gain, and reduces new fat deposition. Moreover, bad cholesterols (LDL, VLDL) are not generated, thus reducing the blood lipid load.
Reesize appears to be very effective when it comes to weight loss. Studies on Orlistat, the active ingredient in Reesize have shown that individuals receiving Orlistat lost significantly more weight compared to those not on Orlistat. In addition to its well-established efficacy in achieving moderate weight loss, Reesize has been shown to improve blood sugars in obese individuals with Type 2 diabetes mellitus as well as some features of metabolic syndrome.
Reesize has also been shown to improve hormonal and metabolic profile in women with polycystic ovarian syndrome after six months of treatment, independently of BMI changes.